Effects of Tofacitinib, an Oral Janus Kinase Inhibitor, on Active Ulcerative Colitis | Medindia
Ulcerative colitis is a long-term inflammatory disorder of the colon and rectum. Study found, tofacitinib to be more effective than placebo in reducing disease activity.
http://www.medindia.net/news/healthwatch/effects-of-tofacitinib-an-oral-janus-kinase-inhibitor-on-active-ulcerative-colitis-106307-1.htm
Ulcerative colitis is a long-term inflammatory disorder of the colon and rectum. Study found, tofacitinib to be more effective than placebo in reducing disease activity.
No comments:
Post a Comment